Improvement of Renal Function After Conversion to Mycophenolate Mofetil Combined With Low-Level Calcineurin Inhibitor in Liver Transplant Recipients With Chronic Renal Dysfunction

Transplantation Proceedings

Volumn 42, Issue 2, 2010, Pages 656-659

  Ponton, C ^a   Vizcaino L ^a   Tome S ^a   Otero, E ^a   Molina, E ^a   Castroagudin J F ^a   Lopez Lago A ^a   Varo Perez E ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTERIAL PRESSURE; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA;

ADOLESCENT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CREATININE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROTHROMBIN TIME;

EID: 77949443498     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.02.006     Document Type: Article

References (17)

1. Gonwa T.A., Mai M.L., Melton L.B., et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation 72 (2001) 1934
2. Pawarode A., Fine D.M., and Thuluwath P.J. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 9 (2003) 741
3. Ojo A.O., Held P.J., Port F.K., et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349 (2003) 931
4. Paramesh A.S., Roayaie S., Doan Y., et al. Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease. Clin Transplant 18 (2004) 94
5. Eugui E.M., Almquist S.J., Muller C.D., et al. Lymphocyte-selective cytostatic and immunosupressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol 33 (1991) 161
6. Allison A.C., Kowalski W.J., Muller C.J., et al. Mycophenolate acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosilation of adhesion molecules. Transplant Proc 25 (1993) 67
7. Stewart S.F., Hudson M., Talbot D., et al. Mycophenolate mofetil monotherapy in liver transplantation. Lancet 357 (2001) 609
8. Pageaux G.P., Rostaing L., Calmus Y., et al. Mycophenolate mofetil in combination with reduction of calcineurin-inhibitors for chronic renal dysfunction after liver transplantation. Liver Transpl 12 (2006) 1755
9. Schlitt H.J., Barkmann A., Boker K.H., et al. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. Lancet 357 (2001) 587
10. Papatheodoris G.V., O'Beirne J., Mistry P., et al. Mycophenolate mofetil monotherapy in stable liver transplant patients with cyclosporine-induced renal impairment: a preliminary report. Transplantation 68 (1999) 155
11. Barkmann A., Nashan B., Schmidt H.H., et al. Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil. Transplantation 69 (2000) 1886
12. Raimondo M.L., Dagher L., Papatheodoridis G.V., et al. Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Transplantation 75 (2003) 186
13. Cantarovich M., Tzimas G.N., Barkun J., et al. Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver transplant patients with renal dysfunction. Transplantation 76 (2003) 98
14. Koch R.O., Graziadei I.W., Schulz F., et al. Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction. Transpl Int 17 (2004) 518
15. Fisher R.A., Stone J.J., Wolfe L.G., et al. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation. Clin Transplant 18 (2004) 463
16. Reich D.J., Clavien P.A., Hodge E.E., and MMF Renal Dysfunction after Liver Transplantation Working Group. Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter, pilot study results. Transplantation 80 (2005) 18
17. Herrero J.I., Quiroga J., Sangro B., et al. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil. iver Transpl Surg 5 (1999) 414